CNE100000PW7
CNE100000PW7
KELUN PHARMA
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 63.19B EUR | 61.28B EUR | 55.44B EUR |
Enterprise Value | 63.5B EUR | 59.54B EUR | 52.78B EUR |
Valuation Multiples | |||
Trailing P/E | 34.54x | 29.96x | 28.35x |
Forward P/E | 26.48x | -- | -- |
Price to Sales | 3.46x | 3.26x | 2.98x |
Price to Book | 2.57x | 2.49x | 2.25x |
EV/Revenue | 3.48x | 3.17x | 2.84x |
EV/EBITDA | 22.99x | 18.56x | 18.74x |
Price to FCF (P/FCF) | 38.34x | 24.05x | 73.37x |
EV/FCF | 38.53x | 23.36x | 69.85x |
FCF Yield | 2.61% | 4.16% | 1.36% |